Form 4: Louise Francesconi Receives 66,667 Restricted Stock Units in Accelerate Diagnostics, Inc.

Director Louise Francesconi was granted 66,667 restricted stock units (RSUs) in Accelerate Diagnostics, Inc. on May 20, 2024, according to a Form 4 filing.

Summary

• On May 20, 2024, Louise Francesconi, a director of Accelerate Diagnostics, Inc., was granted 66,667 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting.
• The RSUs vest on the first-year anniversary of the grant date, provided the reporting person remains in good standing.
• If the reporting person leaves in good standing before the vesting date, the RSUs will vest pro-rata based on months served.
• Following the transaction, Francesconi directly owns 66,667 derivative securities.

Sentiment

Score: 7

Explanation: The document indicates a standard compensation practice, suggesting stability and alignment of interests. The sentiment is neutral to positive.

Positives

• The grant of RSUs aligns the director's interests with the company's performance and shareholder value.

Future Outlook

The vesting of the RSUs is contingent upon continued service, incentivizing the director's ongoing contribution to the company.

Industry Context

Granting stock options and restricted stock units is a common practice for compensating directors and aligning their interests with those of shareholders in publicly traded companies.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term success.

Key Dates